Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine for persistent allergic rhinitis in children (6–11 years)
2008-005939-15Phase 3Completed
- Sponsor
- Uriach
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in persistent allergic rhinitis (PAR) and perennial rhinitis comparing Rupatadine with Placebo (2 arms). Primary endpoint: Change from baseline in Total 4 Symptoms Score (T4SS) over 28 days. Started Nov 2008; status: completed.
02
Drugs
rupatadine
03
Conditions
persistent allergic rhinitis (PAR)perennial rhinitis
Beyond the preview
Go deeper on 2008-005939-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005939-15.